Abstract
It is well established that avian oviposition is regulated, at least partly, by a neurohypophysial hormone, arginine vasotocin, and ovarian hormones, prostaglandins, are regulated through mechanisms of the induction of uterine contractions. Although abundant nerves are terminated in the musculature in the uterine and vaginal oviduct regions, limited information is available on the neuronal control mechanism of avian oviposition. To identify the oviduct factor that plays an important role in the induction of oviposition as a neurotransmitter or a neuromodulator, a study was conducted to isolate the bioactive substance involved in the vaginal and uterine contractions from mature oviducts of the Japanese quail. Acetic acid extracts of 200 quail oviducts were forced through disposable C-18 reversed-phase cartridges, and then the retained material was subjected to the reversed- phase and cation-exchange HPLC purifications. A purified bioactive substance showed a single peak on the reversed phase HPLC and was further subjected to amine acid sequence analysis and molecular weight presumption. The substance was identified as avian galanin, which was previously isolated from chicken intestine. The synthetic peptide enhanced contractions of both the vagina and the uterus in a manner similar to the native peptide, and the threshold concentrations were 10-9-10-8 M in the vagina and 10-10-10-9 M in the uterus. An intraperitoneal injection of the synthetic peptide significantly evoked quail oviposition during 5 min after injection. Immunohistochemical analysis with the anti-galanin serum revealed that abundant immunoreactive fibers were distributed in muscle layers of the vagina and the uterus. The immunoreaction examined in these regions was completely inhibited by preincubation of the antibody with synthetic peptide. These results suggest that avian galanin in the oviduct evokes oviposition through mechanisms of the induction of uterine and vaginal contractions. This peptide may contribute as a neurotransmitter or a neuromodulator to avian oviposition.
| Original language | English |
|---|---|
| Pages (from-to) | 1618-1626 |
| Number of pages | 9 |
| Journal | Endocrinology |
| Volume | 137 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 1996 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Endocrinology
- Endocrinology, Diabetes and Metabolism
Cite this
An oviposition-inducing peptide : Isolation, localization, and function of avian galanin in the quail oviduct. / Li, Dan; Tsutsui, Kazuyoshi; Muneoka, Yojiro; Minakata, Hiroyuki; Nomoto, Kyosuke.
In: Endocrinology, Vol. 137, No. 5, 1996, p. 1618-1626.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - An oviposition-inducing peptide
T2 - Isolation, localization, and function of avian galanin in the quail oviduct
AU - Li, Dan
AU - Tsutsui, Kazuyoshi
AU - Muneoka, Yojiro
AU - Minakata, Hiroyuki
AU - Nomoto, Kyosuke
PY - 1996
Y1 - 1996
N2 - It is well established that avian oviposition is regulated, at least partly, by a neurohypophysial hormone, arginine vasotocin, and ovarian hormones, prostaglandins, are regulated through mechanisms of the induction of uterine contractions. Although abundant nerves are terminated in the musculature in the uterine and vaginal oviduct regions, limited information is available on the neuronal control mechanism of avian oviposition. To identify the oviduct factor that plays an important role in the induction of oviposition as a neurotransmitter or a neuromodulator, a study was conducted to isolate the bioactive substance involved in the vaginal and uterine contractions from mature oviducts of the Japanese quail. Acetic acid extracts of 200 quail oviducts were forced through disposable C-18 reversed-phase cartridges, and then the retained material was subjected to the reversed- phase and cation-exchange HPLC purifications. A purified bioactive substance showed a single peak on the reversed phase HPLC and was further subjected to amine acid sequence analysis and molecular weight presumption. The substance was identified as avian galanin, which was previously isolated from chicken intestine. The synthetic peptide enhanced contractions of both the vagina and the uterus in a manner similar to the native peptide, and the threshold concentrations were 10-9-10-8 M in the vagina and 10-10-10-9 M in the uterus. An intraperitoneal injection of the synthetic peptide significantly evoked quail oviposition during 5 min after injection. Immunohistochemical analysis with the anti-galanin serum revealed that abundant immunoreactive fibers were distributed in muscle layers of the vagina and the uterus. The immunoreaction examined in these regions was completely inhibited by preincubation of the antibody with synthetic peptide. These results suggest that avian galanin in the oviduct evokes oviposition through mechanisms of the induction of uterine and vaginal contractions. This peptide may contribute as a neurotransmitter or a neuromodulator to avian oviposition.
AB - It is well established that avian oviposition is regulated, at least partly, by a neurohypophysial hormone, arginine vasotocin, and ovarian hormones, prostaglandins, are regulated through mechanisms of the induction of uterine contractions. Although abundant nerves are terminated in the musculature in the uterine and vaginal oviduct regions, limited information is available on the neuronal control mechanism of avian oviposition. To identify the oviduct factor that plays an important role in the induction of oviposition as a neurotransmitter or a neuromodulator, a study was conducted to isolate the bioactive substance involved in the vaginal and uterine contractions from mature oviducts of the Japanese quail. Acetic acid extracts of 200 quail oviducts were forced through disposable C-18 reversed-phase cartridges, and then the retained material was subjected to the reversed- phase and cation-exchange HPLC purifications. A purified bioactive substance showed a single peak on the reversed phase HPLC and was further subjected to amine acid sequence analysis and molecular weight presumption. The substance was identified as avian galanin, which was previously isolated from chicken intestine. The synthetic peptide enhanced contractions of both the vagina and the uterus in a manner similar to the native peptide, and the threshold concentrations were 10-9-10-8 M in the vagina and 10-10-10-9 M in the uterus. An intraperitoneal injection of the synthetic peptide significantly evoked quail oviposition during 5 min after injection. Immunohistochemical analysis with the anti-galanin serum revealed that abundant immunoreactive fibers were distributed in muscle layers of the vagina and the uterus. The immunoreaction examined in these regions was completely inhibited by preincubation of the antibody with synthetic peptide. These results suggest that avian galanin in the oviduct evokes oviposition through mechanisms of the induction of uterine and vaginal contractions. This peptide may contribute as a neurotransmitter or a neuromodulator to avian oviposition.
UR - http://www.scopus.com/inward/record.url?scp=0029863841&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029863841&partnerID=8YFLogxK
U2 - 10.1210/en.137.5.1618
DO - 10.1210/en.137.5.1618
M3 - Article
C2 - 8612493
AN - SCOPUS:0029863841
VL - 137
SP - 1618
EP - 1626
JO - Endocrinology
JF - Endocrinology
SN - 0013-7227
IS - 5
ER -